This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Shuntaro Oka: Innovator in Diagnostic Imaging
Introduction
Shuntaro Oka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of cancer-related conditions. His innovative work focuses on developing agents that enhance the detection of diseases at an early stage.
Latest Patents
Shuntaro Oka holds a patent for a diagnostic imaging agent specifically designed for early bone metastasis from cancer. This agent contains trans-1-amino-[F]fluorocyclobutanecarboxylic acid or a pharmaceutically acceptable salt thereof as an active ingredient. This advancement is crucial for improving the accuracy of cancer diagnoses and potentially increasing survival rates through early intervention.
Career Highlights
Oka is associated with Nihon Medi-Physics Company, Limited, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in the advancement of diagnostic technologies.
Collaborations
Shuntaro Oka collaborates with notable colleagues, including Masaru Kanagawa and Masako Teramachi. Their combined expertise contributes to the ongoing development of effective diagnostic tools in the medical industry.
Conclusion
Shuntaro Oka's contributions to diagnostic imaging represent a significant step forward in cancer detection. His innovative approach and collaboration with talented professionals underscore the importance of teamwork in advancing medical technology.